Drugs you can't have Stuff.co.nz, New Zealand - Nov 30, 2008 ... has shown to be highly effective when used in combination with chemotherapy on patients with low-grade non-Hodgkin lymphoma, a kind of blood cancer. ...
The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma Journal of American Medical Association (subscription), IL - Nov 4, 2008 The incidence of non-Hodgkin lymphoma (NHL) increased by more than 80% between 1975 and 1991 in the United States, representing one of the largest increases ...
Dermatolgy office to open in Easton on Dec. 8 The Patriot Ledger, MA - Nov 17, 2008 The new capabilities will include narrow band UVB phototherapy for people with psoriasis, eczema and cutaneous T-cell lymphoma, hand and foot phototherapy ...
'Vitamin' D not a vitamin, but necessary for health Santa Rosa Press Democrat, CA - Nov 25, 2008 A partial list includes Type I diabetes, hypertension, congestive heart failure, schizophrenia, depression, multiple sclerosis, dental caries and psoriasis. ...
Micromet Added to NASDAQ Biotechnology Index MarketWatch - Nov 26, 2008 ... has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. ...TO - MITI - IBB
FDA Approves Deadly Enbrel Drug for Children Natural News.com, AZ - Nov 11, 2008 Enbrel is currently approved for the treatment of rheumatoid arthritis in both adults and children, and for the treatment of moderate to severe psoriasis in ...
Implants: Scientists finally make the connection to breast cancer What Doctors Don't Tell You, UK - Nov 5, 2008 ... Non-Hodgkin's lymphoma the cancer that killed Jackie Kennedy Onassis has been linked to ultraviolet light, used by sunbeds and for treating psoriasis. ...
August is Psoriasis Awareness Month MarketWatch - Psoriasis is a noncontagious, chronic disease of the immune system that appears on the skin, causing red, scaly patches. Many of the estimated 7.5 million ...
Manhattan Falls Short on Phase II Trial for Psoriasis FDA news (subscription), VA - Manhattan Pharmaceuticals? Phase IIa clinical study of topical PTH (1-34) for the treatment of mild-to-moderate plaque psoriasis failed to improve patients? ...OTC:MHAN
When health problems are skin deep Chester DailyLocal.com, USA - Aug 4, 2008 Psoriasis, a chronic skin disorder, is one such condition. August is National Psoriasis Month, and several area medical professionals recently shared their ...
NullHap - a versatile application to estimate haplotype ... 7thSpace Interactive (press release), NY - As an example of application we used Nullhap to reanalyze published data on distribution of KIR genotypes in Polish psoriasis patients and controls showing ...
Model Focus Vogue.com, UK - I used to have psoriasis until about 12 years ago, which has always kept me humble. But every model goes through turbulence so you have to work out what ...
Physical and psychologic measures are necessary to assess overall psoriasis severity. - B Kirby, HL Richards, P Woo, E Hindle, CJ Main, CE … - J Am Acad Dermatol, 2001 - ncbi.nlm.nih.gov ... depression and anxiety subscale scores of HADS (r = 0.33 and r = 0.37; P <.01 ... 01),
and the belief that stress or worry were associated with psoriasis (r = 0.33 ...
Patient Measurement of Psoriasis Disease Severity with a Structured Instrument. - AB Fleischer Jr, SR Rapp, DM Reboussin, JC … - Journal of Investigative Dermatology, 1994 - nature.com ... compared to investigator PASI measurements in 43 patients with mild to severe psoriasis. ...
p < 0.0001) and the investigator global score (r 2 = 0.37, p < 0.0001 ...
Role of Depression in Quality of Life for Patients with Psoriasis - JM Schmitt, DE Ford - Dermatology, 2007 - content.karger.com ... more severe psoriasis were less likely depressed, although this association failed
to reach statistical significance (multiadjusted odds ratio 0.37; 95% CI 0.13 ...
… of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis - KA Papp, L Guenther, B Boyden, FG Larsen, RJ … - Journal of the American Academy of Dermatology, 2003 - Elsevier ... in psoriasis gradings of redness and scaliness of the target lesion were consistent
with the ... group was 0.14 (95% CI, 0.10-0.20), to betametha- sone 0.37 (95% CI ...
Coping and quality of life in patients with psoriasis - A Wahl, BR Hanestad, I Wiklund, T Moum - Quality of Life Research, 1999 - Springer ... 0.00 0.08 0.08 The perception of living with psoriasis A0.54*** A0.29***
0.30*** 0.09 0.37*** 0.19** 0.20** 0.02 Perceived social ...
Under the Skin: A Link Between Psoriasis and Lymphoma?
It turns out that psoriasis, a chronic skin condition that causes itchy, scaly red patches, is more than skin deep. Over the last decade, researchers discovered that psoriasis is due to a problem not with the skin but with the immune system—and a recent study has linked the condition to lymphoma, which is a cancer of the immune system. The study, published in the November 2003 issue of the Archives of Dermatology, found that the rate of lymphoma in people with psoriasis was almost three times higher than the rate in people without the skin condition. But it’s yet not clear what caused the increase in lymphomas.
Over a 46-month period, researchers examined patients aged 65 and older in the United Kingdom who were seen by a doctor registered with the General Practice Research database. While 2,718 patients had psoriasis, 105,203 did not. Researchers found that there were 122 more lymphomas annually per 100,000 patients among the group with psoriasis, compared with those without psoriasis.
Joel M. Gelfand, MD, the principle investigator and an assistant professor at the University of Pennsylvania in Pittsburgh says larger studies need to be done in determine the reason for the increase.
"People with significant psoriasis may be at risk for immune cancers like lymphoma because they have extra immune activity, which increases the risk of your immune cells going awry." Dr. Gelfand says. "Or some of the treatment that suppresses the immune system could increase risk. Or the increase could be due to a combination of these factors."
Dr. Gelfand emphasizes that the rate of lymphoma among people with psoriasis is still low, but that the risks and benefits of treatments for psoriasis should be weighed carefully.
